HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniel Curcio Selected Research

Tigecycline (Tygacil)

6/2011Skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus: role of tigecycline.
4/2011Tigecycline for treating ventilator-associated pneumonia: a practical perspective.
2/2011Tigecycline treatment of critically ill patients: the LatinUser experience.
2/2011Tigecycline for severe infections: the gap between the warning and the necessity.
3/2010Tigecycline in the treatment of ventilator-associated pneumonia: experience from the Latin American Tigecycline Use Registry.
11/2008Comment: tigecycline for the treatment of Acinetobacter infections: a case series.
10/2008Rates of antimicrobial resistance in Latin America (2004-2007) and in vitro activity of the glycylcycline tigecycline and of other antibiotics.
7/2008Tigecycline for treating bloodstream infections: a critical analysis of the available evidence.
6/2008Indications of a new antibiotic in clinical practice: results of the tigecycline initial use registry.
12/2007[Initial use of tigecycline in Argentina].
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daniel Curcio Research Topics

Disease

10Infections
08/2022 - 09/2005
7Ventilator-Associated Pneumonia
11/2015 - 12/2007
4Intraabdominal Infections
01/2016 - 12/2007
2Pneumonia (Pneumonitis)
11/2015 - 06/2010
2Critical Illness (Critically Ill)
02/2011 - 02/2007
1COVID-19
08/2022
1Breakthrough Infections
01/2021
1Hematologic Neoplasms (Hematological Malignancy)
01/2021
1Diarrhea
01/2021
1Respiratory Tract Infections (Respiratory Tract Infection)
11/2015
1Soft Tissue Infections
06/2011
1Bacterial Pneumonia
02/2011
1Acinetobacter Infections
11/2008
1Cross Infection (Nosocomial Infection)
10/2008
1Sepsis (Septicemia)
07/2008
1Vomiting
09/2005
1Pruritus (Itching)
09/2005
1Nausea
09/2005
1Exanthema (Rash)
09/2005
1Dyspepsia (Indigestion)
09/2005
1Anorexia
09/2005

Drug/Important Bio-Agent (IBA)

12Tigecycline (Tygacil)FDA Link
06/2011 - 09/2005
6Anti-Bacterial Agents (Antibiotics)IBA
11/2015 - 12/2007
2COVID-19 VaccinesIBA
08/2022 - 01/2021
2Pharmaceutical PreparationsIBA
02/2011 - 06/2008
1VaccinesIBA
08/2022
1mRNA VaccinesIBA
08/2022
1Neutralizing AntibodiesIBA
08/2022
1Messenger RNA (mRNA)IBA
08/2022
1AntimetabolitesIBA
01/2021
1BNT162 VaccineIBA
01/2021
1avibactamIBA
02/2011
1Ceftazidime (Fortum)FDA LinkGeneric
02/2011
1Oxacillin (Prostaphlin)FDA LinkGeneric
02/2011
1VancomycinFDA LinkGeneric
09/2005
1CL 331002 (glycylcycline)IBA
09/2005
1AztreonamFDA LinkGeneric
09/2005
1Alanine Transaminase (SGPT)IBA
09/2005

Therapy/Procedure

4Therapeutics
01/2016 - 06/2010
3Off-Label Use
02/2011 - 12/2007
2Mechanical Ventilators (Ventilator)
11/2015 - 02/2014
1Length of Stay
01/2021
1Artificial Respiration (Mechanical Ventilation)
11/2015